Glycine
- Generic Name
- Glycine
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C2H5NO2
- CAS Number
- 56-40-6
- Unique Ingredient Identifier
- TE7660XO1C
- Background
A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
- Indication
Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
- Associated Conditions
- Coronary vascular graft occlusion, Deep Vein Thrombosis, Myocardial Infarction, Stroke, Transient Ischemic Attack, Vascular Occlusion
- Associated Therapies
- Bladder distension, Bladder irrigation therapy, Irrigation therapy, Recovery, Amino acid supplementation
Glycine to Treat Psychotic Disorders in Children
Phase 2
Completed
- Conditions
- First Posted Date
- 2000-05-10
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 10
- Registration Number
- NCT00005658
- Locations
- 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States
Glycine and D-Cycloserine in Schizophrenia
Phase 3
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2014-06-12
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT00000372
- Locations
- 🇺🇸
Freedom Trail Clinic, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath